Dr. Lal PathLabs Limited announced on March 25, 2026, that its Issuer Rating has been upgraded by CARE Ratings Limited. The rating moved from CARE AA; Stable to CARE AA+; Stable. This upgrade reflects the positive operational and financial performance demonstrated by the company through FY25 (Audited) and 9MFY26 (Un-audited), signaling strong overall creditworthiness.
Credit Rating Enhancement Announced
Dr. Lal PathLabs Limited has formally informed stock exchanges regarding a significant enhancement in its credit profile. On March 25, 2026, the company received confirmation that CARE Ratings Limited has upgraded its Issuer Rating. The rating action signifies an improved assessment of the company’s general creditworthiness based on recent performance metrics.
Details of the Rating Upgrade
The rating review considered the operational and financial performance spanning the full fiscal year FY25 (Audited) and the first nine months of the current fiscal year, 9MFY26 (Un-audited). The Rating Committee concluded the review by implementing the following change:
- Type of Rating: Issuer Rating
- Previous Rating: CARE AA; Stable
- New Rating: CARE AA+; Stable
- Rating Action: Upgraded
The company confirmed that the formal letter detailing this upgrade has been attached to the regulatory filing for immediate record-keeping by the exchange authorities.
Forward-Looking Statements on Ratings
The rating agency noted that the rating assigned is an opinion on the general creditworthiness and does not pertain to any specific debt instrument. Furthermore, the rating is subject to periodic surveillance reviews, which the company is expected to fully cooperate with by providing necessary documentation and clarifications as required.
Source: BSE
